The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy

scientific article

The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1044530968
P356DOI10.1038/EJHG.2012.156
P3181OpenCitations bibliographic resource ID704119
P932PMC publication ID3573195
P698PubMed publication ID22872100
P5875ResearchGate publication ID230632625

P50authorStefano SartoriQ41190210
John ChristodoulouQ42753915
Stephanie FehrQ58415023
Jenny DownsQ88047935
P2093author name stringMeredith Wilson
Stavroula Psoni
Alessandra Murgia
Gladys Ho
Helen Leonard
Marilena Vecchi
Nick de Klerk
Roberta Polli
Simon Williams
Xinhua Bao
P2860cites workFunctional consequences of mutations in CDKL5, an X-linked gene involved in infantile spasms and mental retardationQ24300800
Disruption of the serine/threonine kinase 9 gene causes severe X-linked infantile spasms and mental retardationQ24532056
Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardationQ24534159
Rett syndrome: revised diagnostic criteria and nomenclatureQ24596295
Novel mutations in the CDKL5 gene, predicted effects and associated phenotypesQ28236247
A novel p.Arg970X mutation in the last exon of the CDKL5 gene resulting in late-onset seizure disorderQ28244391
Alu-specific microhomology-mediated deletions in CDKL5 in females with early-onset seizure disorderQ28246317
Re: CDKL5 mutations in boys with severe encephalopathy and early-onset intractable epilepsyQ28250359
Impairment of CDKL5 nuclear localisation as a cause for severe infantile encephalopathyQ28256843
Xp22.3 genomic deletions involving the CDKL5 gene in girls with early onset epileptic encephalopathyQ28259617
Mutational spectrum of CDKL5 in early-onset encephalopathies: a study of a large collection of French patients and review of the literatureQ28260011
The three stages of epilepsy in patients with CDKL5 mutationsQ28268280
Seizures and electroencephalographic findings in CDKL5 mutations: case report and reviewQ28269052
Identification of the epileptogenic tuber in patients with tuberous sclerosis: a comparison of high-resolution EEG and MEGQ28292197
Key clinical features to identify girls with CDKL5 mutationsQ28293847
CDKL5 mutations in boys with severe encephalopathy and early-onset intractable epilepsyQ28294905
Investigating genotype-phenotype relationships in Rett syndrome using an international data set.Q31149239
Angelman's syndromeQ33597572
Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation.Q33910551
The core FOXG1 syndrome phenotype consists of postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and corpus callosum hypogenesisQ33924011
WHO Motor Development Study: windows of achievement for six gross motor development milestonesQ36525973
CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients.Q36930153
Epilepsy caused by CDKL5 mutations.Q37759629
Mutation screening of the CDKL5 gene in cryptogenic infantile intractable epilepsy and review of clinical sensitivityQ37903119
Early progressive encephalopathy in boys and MECP2 mutationsQ41919344
The clinical pattern of the Rett syndromeQ41934117
Identification of a novel CDKL5 exon and pathogenic mutations in patients with severe mental retardation, early-onset seizures and Rett-like features.Q45970066
Epileptic encephalopathy in a girl with an interstitial deletion of Xp22 comprising promoter and exon 1 of the CDKL5 gene.Q46004507
Early-onset seizure variant of Rett syndrome: definition of the clinical diagnostic criteria.Q48017922
A girl with early-onset epileptic encephalopathy associated with microdeletion involving CDKL5.Q48984134
CDKL5 alterations lead to early epileptic encephalopathy in both gendersQ49032666
Cyclin-dependent kinase-like 5 (CDKL5) mutation screening in Rett syndrome and related disordersQ50304287
Altered attainment of developmental milestones influences the age of diagnosis of rett syndrome.Q51467838
Pathogenic role of the X-linked cyclin-dependent kinase-like 5 and aristaless-related homeobox genes in epileptic encephalopathy of unknown etiology with onset in the first year of life.Q51804552
CDKL5 gene-related epileptic encephalopathy: electroclinical findings in the first year of life.Q51889095
Early-onset seizures due to mosaic exonic deletions of CDKL5 in a male and two females.Q51889620
Encephalopathy and bilateral cataract in a boy with an interstitial deletion of Xp22 comprising the CDKL5 and NHS genes.Q51907594
Early onset seizures and Rett-like features associated with mutations in CDKL5.Q51928093
Analysis of Hungarian patients with Rett syndrome phenotype for MECP2, CDKL5 and FOXG1 gene mutations.Q52606025
The Pitt-Hopkins syndrome: report of 16 new patients and clinical diagnostic criteria.Q52612488
Clinical phenotype of 5 females with a CDKL5 mutation.Q54252592
CDKL5 truncation due to a t(X;2)(p22.1;p25.3) in a girl with X-linked infantile spasm syndrome.Q54716684
A novel mutation in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene associated with a severe Rett phenotype.Q54764790
CDKL5 MUTATIONS IN BOYS WITH SEVERE ENCEPHALOPATHY AND EARLY-ONSET INTRACTABLE EPILEPSYQ56592648
A distinctive seizure type in patients with CDKL5 mutations: Hypermotor-tonic-spasms sequenceQ57927167
Is the girl with Rett syndrome normal at birth?Q74266188
Maternal origin of a novel C-terminal truncation mutation in CDKL5 causing a severe atypical form of Rett syndromeQ79822761
Rett syndrome: a study of the faceQ84231462
Somatic mosaicism for a CDKL5 mutation as an epileptic encephalopathy in malesQ84524320
Simultaneous onset of infantile spasms in monozygotic twinsQ84540038
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectCDKL5 deficiency disorderQ40739448
P304page(s)266-73
P577publication date2013-03-01
P1433published inEuropean Journal of Human GeneticsQ2155433
P1476titleThe CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy
P478volume21

Reverse relations

cites work (P2860)
Q64039399Analysis of the Phenotypes in the Rett Networked Database
Q89805320CDKL5 Deficiency Disorder-A Complex Epileptic Encephalopathy
Q35915948CDKL5 and Shootin1 Interact and Concur in Regulating Neuronal Polarization
Q38946519CDKL5 deficiency entails sleep apneas in mice
Q39827058CDKL5 knockout leads to altered inhibitory transmission in the cerebellum of adult mice.
Q47134048CDKL5 variants: Improving our understanding of a rare neurologic disorder
Q36055559Characterisation of CDKL5 Transcript Isoforms in Human and Mouse
Q62084107Chemical genetic identification of CDKL5 substrates reveals its role in neuronal microtubule dynamics
Q38375116Clinical and biological progress over 50 years in Rett syndrome.
Q35101573Clinical features and gene mutational spectrum of CDKL5-related diseases in a cohort of Chinese patients
Q47388004Comparing Parental Well-Being and Its Determinants Across Three Different Genetic Disorders Causing Intellectual Disability.
Q64939210Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review.
Q35876723Cytokine Dysregulation in MECP2- and CDKL5-Related Rett Syndrome: Relationships with Aberrant Redox Homeostasis, Inflammation, and ω-3 PUFAs
Q30661397Deletion of protein tyrosine phosphatase, non-receptor type 4 (PTPN4) in twins with a Rett syndrome-like phenotype
Q54199836FOXG1 Mutation is a Low-Incidence Genetic Cause in Atypical Rett Syndrome.
Q55017288Functional abilities in children and adults with the CDKL5 disorder.
Q64078571Functional and Structural Impairments in the Perirhinal Cortex of a Mouse Model of CDKL5 Deficiency Disorder Are Rescued by a TrkB Agonist
Q53118141Further Clinical Delineation of the MEF2C Haploinsufficiency Syndrome: Report on New Cases and Literature Review of Severe Neurodevelopmental Disorders Presenting with Seizures, Absent Speech, and Involuntary Movements.
Q36805699Genetic forms of epilepsies and other paroxysmal disorders
Q48599692HDAC4: a key factor underlying brain developmental alterations in CDKL5 disorder
Q55436457Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder.
Q47841401Heterozygous truncation mutations of the SMC1A gene cause a severe early onset epilepsy with cluster seizures in females: Detailed phenotyping of 10 new cases
Q42046503Identification of an elaborate complex mediating postsynaptic inhibition
Q37595707Impacts of caring for a child with the CDKL5 disorder on parental wellbeing and family quality of life
Q36886682Improving diagnosis and broadening the phenotypes in early-onset seizure and severe developmental delay disorders through gene panel analysis.
Q89460115Increased DNA Damage and Apoptosis in CDKL5-Deficient Neurons
Q35595321Integrated analysis of whole-exome sequencing and transcriptome profiling in males with autism spectrum disorders
Q36504423Loss of CDKL5 disrupts kinome profile and event-related potentials leading to autistic-like phenotypes in mice.
Q50225101MECP2 mutations in Czech patients with Rett syndrome and Rett-like phenotypes: novel mutations, genotype-phenotype correlations and validation of high-resolution melting analysis for mutation scanning
Q33623490Mapping pathological phenotypes in a mouse model of CDKL5 disorder
Q92782695Microtubules: A Key to Understand and Correct Neuronal Defects in CDKL5 Deficiency Disorder?
Q33752190Molecular and genetic insights into an infantile epileptic encephalopathy - CDKL5 disorder
Q52695037Mutation in an alternative transcript of CDKL5 in a boy with early onset seizures.
Q55253870Mutations in epilepsy and intellectual disability genes in patients with features of Rett syndrome.
Q36180117Neurobehavioral phenotype in cyclin-dependent kinase-like 5 syndrome: Case report and review of literature
Q63976989Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase
Q28274920Prevalence and onset of comorbidities in the CDKL5 disorder differ from Rett syndrome
Q56018329Quantitative phosphoproteomic analysis of the molecular substrates of sleep need
Q90748674Rett Syndrome and CDKL5 Deficiency Disorder: From Bench to Clinic
Q50422613Rett syndrome: a neurological disorder with metabolic components
Q37294375Rett syndrome: a wide clinical and autonomic picture.
Q53752724RettBASE: Rett syndrome database update.
Q33762246Searching for biomarkers of CDKL5 disorder: early-onset visual impairment in CDKL5 mutant mice
Q36103911Sequential Elution Interactome Analysis of the Mind Bomb 1 Ubiquitin Ligase Reveals a Novel Role in Dendritic Spine Outgrowth
Q92874536Splicing Mutations Impairing CDKL5 Expression and Activity Can be Efficiently Rescued by U1snRNA-Based Therapy
Q38122234Structural characterization of the cyclin-dependent protein kinase family
Q57267880Synaptic Disorders
Q38125969Synaptic plasticity and signaling in Rett syndrome.
Q26800087The Utility of Next-Generation Sequencing in Gene Discovery for Mutation-Negative Patients with Rett Syndrome
Q38501842The genetics of the epilepsies.
Q89596064The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo
Q48548114The neurosteroid pregnenolone reverts microtubule derangement induced by the loss of a functional CDKL5-IQGAP1 complex
Q35053870There is variability in the attainment of developmental milestones in the CDKL5 disorder.
Q55654628Transcriptome level analysis in Rett syndrome using human samples from different tissues.
Q48284886Two Siblings With a CDKL5 Mutation: Genotype and Phenotype Evaluation
Q37741362Unexplained Early Infantile Epileptic Encephalopathy in Han Chinese Children: Next-Generation Sequencing and Phenotype Enriching
Q38730212Use of the ketogenic diet to manage refractory epilepsy in CDKL5 disorder: Experience of >100 patients.

Search more.